
Human papillomavirus screening (HPV)
The most important risk factor for cervical cancer is infection with human papillomavirus (HPV). It is diagnosed in over 99% of cervical cancer patients.
There are different types of HPV which are grouped according to the severity of their cancer risk. More than 150 HPV types have been described. Many of them are not very dangerous but several dozen are classified as having a higher risk, and HPV 16 and HPV 18 are classified as “high risk”. Oncogenic qualities are also attributed to HPV types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59.
Most HPV infections are asymptomatic and go away by themselves. Statistically, five out of ten sexually active women sooner or later will contract the virus but only a few of them will get pre-cancerous or cancerous abnormalities resulting from the infection.
Whether the cervix has been infected with HPV can be established with the help of the liquid based oncocytology test, and the virus test. These tests will show if the woman has contracted the virus.
For 100% protection from cervical cancer we recommend that these two tests are performed together – human papillomavirus (HPV) and cervical cytology (PAP).
The world medical community unanimously agrees that it is much easier to avoid cervical cancer than to treat it. Copy chartEdit chartPublish chartDownload chart
You must make an appointment with a gynaecologist for this test, as they will take a sample of the cells of your cervix.
Test price
What factors affect the price?
The prices indicated below apply to citizens of the Republic of Lithuania and the European Union.
If you are coming from another country please check the price by telephoning or sending an email.
Why it is worth
to be examined at our Centre?
- The main test results are available within 1–2 hours.
- We perform high quality tests which has been confirmed by the ISO 15189 certification of our laboratory.
- The results of the tests performed in our laboratory are explained by our staff, a service that is provided by only a few laboratories in the country.
- There is no risk of damage or mix-up of test samples during transportation.